Teacher Retirement System of Texas Increases Position in AdaptHealth Corp. (NASDAQ:AHCO)

Teacher Retirement System of Texas grew its position in AdaptHealth Corp. (NASDAQ:AHCO) by 134.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 45,225 shares of the company’s stock after purchasing an additional 25,909 shares during the quarter. Teacher Retirement System of Texas’ holdings in AdaptHealth were worth $431,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of AHCO. Barclays PLC raised its stake in AdaptHealth by 361.3% in the third quarter. Barclays PLC now owns 181,240 shares of the company’s stock valued at $2,034,000 after buying an additional 141,949 shares in the last quarter. Principal Financial Group Inc. increased its holdings in shares of AdaptHealth by 39.7% in the 3rd quarter. Principal Financial Group Inc. now owns 543,744 shares of the company’s stock valued at $6,106,000 after acquiring an additional 154,434 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of AdaptHealth by 73.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 191,833 shares of the company’s stock worth $2,154,000 after acquiring an additional 81,097 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in AdaptHealth by 7.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 162,470 shares of the company’s stock worth $1,825,000 after purchasing an additional 11,757 shares during the last quarter. Finally, Reinhart Partners LLC. increased its stake in AdaptHealth by 1.1% in the fourth quarter. Reinhart Partners LLC. now owns 6,266,854 shares of the company’s stock valued at $59,660,000 after purchasing an additional 68,212 shares during the last quarter. 82.67% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

AHCO has been the subject of several recent analyst reports. Robert W. Baird boosted their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. Royal Bank of Canada boosted their price target on shares of AdaptHealth from $11.00 to $14.00 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. UBS Group decreased their price objective on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Truist Financial lifted their target price on AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Finally, Canaccord Genuity Group boosted their target price on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a report on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $13.80.

AdaptHealth Trading Up 1.9 %

Shares of AdaptHealth stock opened at $10.84 on Tuesday. The company’s fifty day moving average is $10.03 and its two-hundred day moving average is $10.16. AdaptHealth Corp. has a 1 year low of $8.35 and a 1 year high of $11.90. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The company has a market capitalization of $1.46 billion, a P/E ratio of -6.57, a PEG ratio of 1.08 and a beta of 1.30.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.